These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11933492)

  • 1. Osmonics says FDA accepts action plan to correct problems at R.O. plant.
    Nephrol News Issues; 2000 Oct; 14(11):13. PubMed ID: 11933492
    [No Abstract]   [Full Text] [Related]  

  • 2. W.R. Grace division under FDA fire--again.
    Burns J
    Mod Healthc; 1995 Apr; 25(16):9. PubMed ID: 10141539
    [No Abstract]   [Full Text] [Related]  

  • 3. On the slow track: the road to FDA approval. Part one of two.
    Boudreau D
    Nephrol News Issues; 1994 Aug; 8(8):16, 18. PubMed ID: 7969545
    [No Abstract]   [Full Text] [Related]  

  • 4. Reaction mixed on value of new FDA regulations for dialyzer relabelling.
    Boudreau D
    Nephrol News Issues; 1995 Oct; 9(10):7-8. PubMed ID: 7494593
    [No Abstract]   [Full Text] [Related]  

  • 5. Grace gets FDA OK to import equipment.
    Burns J
    Mod Healthc; 1993 Aug; 23(33):22. PubMed ID: 10127633
    [No Abstract]   [Full Text] [Related]  

  • 6. The need for a manual on quality assurance for hemodialysis devices.
    Thomas AW; Pijar ML
    Nephrol News Issues; 1991 Apr; 5(4):20. PubMed ID: 1961280
    [No Abstract]   [Full Text] [Related]  

  • 7. Living day-to-day with kidney dialysis. Quality improvements continue for devices and clinics.
    Williams RD
    FDA Consum; 1998; 32(1):11-5. PubMed ID: 9508544
    [No Abstract]   [Full Text] [Related]  

  • 8. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three deaths associated with excess aluminum in dialysate.
    Nephrol News Issues; 1992 Jul; 6(7):10. PubMed ID: 1407047
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical product integrity: can the FDA assure quality?
    Bernstein I
    Manag Care; 2004 Mar; 13(3 Suppl):30-3. PubMed ID: 15074168
    [No Abstract]   [Full Text] [Related]  

  • 11. Check for 510(k) clearance before buying a repackaged portable water-treatment system.
    Health Devices; 2003 Dec; 32(12):485-6. PubMed ID: 14983565
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA initiative will enhance drug good manufacturing practices.
    FDA Consum; 2002; 36(6):4. PubMed ID: 12523283
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA final guidance on software validation.
    Donawa M
    Med Device Technol; 2002 Apr; 13(3):20-4. PubMed ID: 12030100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using CQI to improve your reuse program.
    Halpin J
    Nephrol News Issues; 1994 Mar; 8(3):24-30. PubMed ID: 7969537
    [No Abstract]   [Full Text] [Related]  

  • 15. EC/FDA joint inspections.
    Nasto B
    Nat Biotechnol; 2008 Aug; 26(8):847. PubMed ID: 18688225
    [No Abstract]   [Full Text] [Related]  

  • 16. [State surveillance and control of food quality and safety in USA].
    Berman VA
    Vopr Pitan; 2003; 72(2):22-7. PubMed ID: 12924205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA restructures new product review centers.
    Bouchie A
    Nat Biotechnol; 2002 Oct; 20(10):960. PubMed ID: 12355100
    [No Abstract]   [Full Text] [Related]  

  • 18. Final FDA acrylamide action plan, data.
    FDA Consum; 2004; 38(3):27. PubMed ID: 15218843
    [No Abstract]   [Full Text] [Related]  

  • 19. Mifepristone approval delayed, supporters look to action by FDA.
    Contracept Technol Update; 2000 May; 21(5):53-5. PubMed ID: 12295903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FDA and radiologists: momentum for change.
    Hillman BJ
    J Am Coll Radiol; 2005 Jun; 2(6):459-60. PubMed ID: 17411858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.